Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients

Last updated: July 30, 2019
Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Overall Status: Active - Recruiting

Phase

2

Condition

Williams Syndrome

Asperger's Disorder

Treatment

N/A

Clinical Study ID

NCT03963479
BSMMU/2018/14607
  • Ages 2-12
  • All Genders

Study Summary

To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Children between 2 to 12 years of age suspected ASD assessed by DSM-5 and ADCL tool

  2. Each patient will be free of psychoactive medication for atleast 3 months prior to theentry into the trial

  3. Newly diagnosed patient

  4. Co-morbid neurological disorder like hyperactivity

Exclusion

Exclusion Criteria:

  1. Patients with chronic diseases or any known metabolic or hormonal diseases

  2. Patients with any known chromosomal or genetic syndromes

  3. Patients unable to give informed consent

  4. Patients unable to travel to clinical visits or non co-operative

Study Design

Total Participants: 50
Study Start date:
January 01, 2019
Estimated Completion Date:
July 31, 2019

Connect with a study center

  • Farhana Khan

    Dhaka, 02
    Bangladesh

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.